StockData
Medline Inc. logo

Medline Inc. (MDLN) stock

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$39.16+1.48 (+3.93%)

Close on Nov 18, 2026Market cap $51.48BP/E –Yield –

Medline revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Medline's revenue for the twelve months ending Sep 26, 2026 was $30.68B. For fiscal 2025 it was $28.43B, up 11.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$28.43B+11.5%
FY2024Dec 31, 2024$25.51B+9.8%
FY2023Dec 31, 2023$23.23B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 26, 2026$7.86B+10.4%
Q2 FY2026Jun 27, 2026$7.69B+11.6%
Q1 FY2026Mar 28, 2026$7.35B+10.7%
Q4 FY2025Dec 31, 2025$7.79B–
Q3 FY2025Sep 27, 2025$7.12B–
Q2 FY2025Jun 28, 2025$6.89B–
Q1 FY2025Mar 29, 2025$6.64B–

More Medline figures

See a number that looks wrong?